NECLIFE

NSI · Equity

Nectar Lifesciences Limited

IN Healthcare Drug Manufacturers - Specialty & Generic

Latest week: 29 May 2026
Close: 12.450000
Fair value: 25.886859
Expectation: Undecided 46.30%

Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending: 29 May 2026
Latest Close: 12.45
12-Week Change: 12.26%
Trend Signal: Inactive
Expectation: Undecided 46.30%
Signal Weeks: 0 of 12
Vs Trend Line: Below
Vs Fair Value: Below
Relative Strength: -14.76
Market Dynamics: 0.53

Over the latest 12 completed weeks ending 2026-05-29, NECLIFE rose 12.26%, moving from 11.09 to 12.45. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -14.76 and has improved across the 12-week window. Market Dynamics is 0.53 on the latest week. Expectation is undecided at 46.30%.